Aspen Aerogels, Inc. (NYSE:ASPN) Receives $50.90 Average Target Price from Analysts

Shares of Aspen Aerogels, Inc. (NYSE:ASPNGet Rating) have been assigned an average rating of “Buy” from the twelve brokerages that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 12-month price objective among analysts that have covered the stock in the last year is $50.90.

ASPN has been the subject of a number of research reports. Zacks Investment Research downgraded Aspen Aerogels from a “buy” rating to a “hold” rating in a research note on Wednesday, May 4th. Benchmark reduced their price target on shares of Aspen Aerogels from $70.00 to $60.00 in a research report on Friday, February 18th. B. Riley lowered their price objective on shares of Aspen Aerogels from $59.00 to $44.00 in a research report on Friday, April 29th. Canaccord Genuity Group cut their target price on shares of Aspen Aerogels from $47.00 to $32.00 and set a “buy” rating on the stock in a report on Tuesday, May 3rd. Finally, Piper Sandler decreased their target price on Aspen Aerogels from $72.00 to $68.00 and set an “overweight” rating for the company in a research note on Friday, February 18th.

NYSE ASPN opened at $17.43 on Friday. The company has a quick ratio of 5.03, a current ratio of 5.37 and a debt-to-equity ratio of 0.55. Aspen Aerogels has a fifty-two week low of $13.74 and a fifty-two week high of $65.99. The business has a 50 day moving average price of $24.97 and a two-hundred day moving average price of $35.91. The stock has a market cap of $628.89 million, a PE ratio of -11.17 and a beta of 1.96.

Aspen Aerogels (NYSE:ASPNGet Rating) last announced its earnings results on Wednesday, April 27th. The construction company reported ($0.59) earnings per share for the quarter, missing the consensus estimate of ($0.48) by ($0.11). Aspen Aerogels had a negative net margin of 38.15% and a negative return on equity of 36.06%. During the same quarter in the previous year, the company earned ($0.22) earnings per share. Sell-side analysts anticipate that Aspen Aerogels will post -1.97 EPS for the current fiscal year.

In related news, major shareholder Koch Industries Inc purchased 1,791,986 shares of Aspen Aerogels stock in a transaction dated Monday, March 28th. The stock was acquired at an average cost of $27.90 per share, with a total value of $49,996,409.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Robert M. Gervis bought 135,870 shares of the stock in a transaction on Tuesday, March 22nd. The stock was purchased at an average price of $33.12 per share, for a total transaction of $4,500,014.40. The disclosure for this purchase can be found here. 13.30% of the stock is currently owned by corporate insiders.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. UBS Group AG increased its holdings in shares of Aspen Aerogels by 0.5% during the third quarter. UBS Group AG now owns 83,503 shares of the construction company’s stock worth $3,842,000 after buying an additional 393 shares in the last quarter. Metropolitan Life Insurance Co NY grew its stake in shares of Aspen Aerogels by 6.5% during the third quarter. Metropolitan Life Insurance Co NY now owns 6,529 shares of the construction company’s stock worth $300,000 after purchasing an additional 400 shares during the period. Captrust Financial Advisors grew its stake in shares of Aspen Aerogels by 451.1% during the first quarter. Captrust Financial Advisors now owns 722 shares of the construction company’s stock worth $25,000 after purchasing an additional 591 shares during the period. Advisor Group Holdings Inc. increased its holdings in Aspen Aerogels by 37.5% in the first quarter. Advisor Group Holdings Inc. now owns 2,539 shares of the construction company’s stock valued at $87,000 after purchasing an additional 692 shares during the last quarter. Finally, First Command Bank bought a new position in Aspen Aerogels during the third quarter worth about $41,000. Hedge funds and other institutional investors own 99.90% of the company’s stock.

About Aspen Aerogels (Get Rating)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets in the United States, Asia, Canada, Europe, and Latin America. The company offers PyroThin thermal barriers for use in lithium-ion batteries in electric vehicles and energy storage industries; Pyrogel XTE that reduces the risk of corrosion under insulation in energy infrastructure operating systems; Pyrogel HPS for applications within the power generation market; Pyrogel XTF to provide protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; and Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production.

Recommended Stories

Analyst Recommendations for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.